urimar-t caps

Generic: methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate

Labeler: allegis pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name urimar-t caps
Generic Name methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate
Labeler allegis pharmaceuticals, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

hyoscyamine sulfate .12 mg/1, methenamine 120 mg/1, methylene blue 10.8 mg/1, phenyl salicylate 36.2 mg/1, sodium phosphate, monobasic, monohydrate 40.8 mg/1

Manufacturer
Allegis Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 28595-224
Product ID 28595-224_2b39f5ac-ab4e-617a-e063-6294a90a4c48
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 2023-06-28

Pharmacologic Class

Classes
oxidation-reduction activity [moa] oxidation-reduction agent [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 28595224
Hyphenated Format 28595-224

Supplemental Identifiers

RxCUI
2637557 2640308
UPC
0328595224602
UNII
F2R8V82B84 J50OIX95QV T42P99266K 28A37T47QO 593YOG76RN

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name urimar-t caps (source: ndc)
Generic Name methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .12 mg/1
  • 120 mg/1
  • 10.8 mg/1
  • 36.2 mg/1
  • 40.8 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (28595-224-60)
source: ndc

Packages (1)

28595-224-60 60 CAPSULE in 1 BOTTLE (28595-224-60)

Ingredients (5)

hyoscyamine sulfate (.12 mg/1) methenamine (120 mg/1) methylene blue (10.8 mg/1) phenyl salicylate (36.2 mg/1) sodium phosphate, monobasic, monohydrate (40.8 mg/1)

Linked Drug Pages (1)

URIMAR-T CAPS ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2b39f5ac-ab4e-617a-e063-6294a90a4c48", "openfda": {"upc": ["0328595224602"], "unii": ["F2R8V82B84", "J50OIX95QV", "T42P99266K", "28A37T47QO", "593YOG76RN"], "rxcui": ["2637557", "2640308"], "spl_set_id": ["cf7c3d65-11d2-49cd-b207-8ccc6a221fe0"], "manufacturer_name": ["Allegis Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (28595-224-60)", "package_ndc": "28595-224-60", "marketing_start_date": "20230628"}], "brand_name": "URIMAR-T CAPS", "product_id": "28595-224_2b39f5ac-ab4e-617a-e063-6294a90a4c48", "dosage_form": "CAPSULE", "pharm_class": ["Oxidation-Reduction Activity [MoA]", "Oxidation-Reduction Agent [EPC]"], "product_ndc": "28595-224", "generic_name": "methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate", "labeler_name": "Allegis Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "URIMAR-T CAPS", "active_ingredients": [{"name": "HYOSCYAMINE SULFATE", "strength": ".12 mg/1"}, {"name": "METHENAMINE", "strength": "120 mg/1"}, {"name": "METHYLENE BLUE", "strength": "10.8 mg/1"}, {"name": "PHENYL SALICYLATE", "strength": "36.2 mg/1"}, {"name": "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE", "strength": "40.8 mg/1"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20230628", "listing_expiration_date": "20261231"}